QTRX Stock Overview
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Quanterix Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$15.59 |
| 52 Week High | US$29.70 |
| 52 Week Low | US$11.60 |
| Beta | 1.33 |
| 1 Month Change | -28.81% |
| 3 Month Change | -33.83% |
| 1 Year Change | 31.67% |
| 3 Year Change | -75.78% |
| 5 Year Change | -29.96% |
| Change since IPO | -10.76% |
Recent News & Updates
Quanterix Corporation's (NASDAQ:QTRX) 31% Cheaper Price Remains In Tune With Revenues
Apr 14
Quanterix (NASDAQ:QTRX) Is In A Strong Position To Grow Its Business
Apr 05Recent updates
Quanterix Corporation's (NASDAQ:QTRX) 31% Cheaper Price Remains In Tune With Revenues
Apr 14Quanterix (NASDAQ:QTRX) Is In A Strong Position To Grow Its Business
Apr 05Quanterix Corporation (NASDAQ:QTRX) Yearly Results: Here's What Analysts Are Forecasting For This Year
Mar 03Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation
Oct 12We're Not Very Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Rate
Jun 12We Think Quanterix (NASDAQ:QTRX) Can Afford To Drive Business Growth
Feb 10Quanterix Corporation: Selling For Less Than Cash Value
Sep 28We Think Quanterix (NASDAQ:QTRX) Can Afford To Drive Business Growth
Sep 23Quanterix stock gains after insider buys reported by CEO and CFO
Aug 17We're Hopeful That Quanterix (NASDAQ:QTRX) Will Use Its Cash Wisely
Mar 28Is Quanterix (NASDAQ:QTRX) A Risky Investment?
Feb 21Shareholder Returns
| QTRX | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -1.3% | 3.6% | 1.0% |
| 1Y | 31.7% | 3.2% | 21.9% |
Return vs Industry: QTRX exceeded the US Life Sciences industry which returned 4.7% over the past year.
Return vs Market: QTRX exceeded the US Market which returned 24.9% over the past year.
Price Volatility
| QTRX volatility | |
|---|---|
| QTRX Average Weekly Movement | 7.8% |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: QTRX's share price has been volatile over the past 3 months.
Volatility Over Time: QTRX's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 441 | Masoud Toloue | www.quanterix.com |
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays.
Quanterix Corporation Fundamentals Summary
| QTRX fundamental statistics | |
|---|---|
| Market cap | US$596.27m |
| Earnings (TTM) | -US$32.33m |
| Revenue (TTM) | US$122.37m |
4.9x
P/S Ratio-18.4x
P/E RatioIs QTRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QTRX income statement (TTM) | |
|---|---|
| Revenue | US$122.37m |
| Cost of Revenue | US$51.72m |
| Gross Profit | US$70.65m |
| Other Expenses | US$102.98m |
| Earnings | -US$32.33m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.85 |
| Gross Margin | 57.73% |
| Net Profit Margin | -26.42% |
| Debt/Equity Ratio | 0% |
How did QTRX perform over the long term?
See historical performance and comparison